Perbedaan Remala Abadi Tbk. dan UBC Medical Indonesia Tbk.: Remala Abadi Tbk. diperdagangkan di Rp2.450 (kapitalisasi pasar 3,29 T, volume 24 jam 15,47 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Remala Abadi Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Remala Abadi Tbk. lebih aktif diperdagangkan (15,47 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DATA | LABS | |
|---|---|---|
Kapitalisasi Pasar | 3,29 T | 584,6 M |
Volume | 15,47 jt | 817,3 rb |
Lot | 154,74 rb | 8,17 rb |
Perputaran | 37,99 M | 120,01 jt |
Harga Rata-rata | 2.454,89 | 146,84 |
Nilai Transaksi | 37,99 M | 120,01 jt |
Harga Ekuilibrium Indikatif | 2.450 | 146 |
Volume Ekuilibrium Indikatif | 2,17 rb | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Selengkapnya di halaman DATA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →